XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
shares in Thousands, $ in Millions
Total
 Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (loss)
Beginning balance (in shares) at Mar. 31, 2023   272,914      
Beginning balance at Mar. 31, 2023 $ 7,293 $ 3 $ 0 $ 7,357 $ (67)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 394     402 (8)
Stock-based compensation 130   130    
Issuance of common stock (in shares)   1,408      
Issuance of common stock $ (105)   (105)    
Common stock repurchases (in shares) (2,600) (2,574)      
Common stock repurchases and excise tax $ (326)        
Common stock repurchases and excise tax (325)   (25) (301)  
Cash dividends declared ($0.19 per common share) (52)     (52)  
Ending balance (in shares) at Jun. 30, 2023   271,748      
Ending balance at Jun. 30, 2023 $ 7,334 $ 3 0 7,406 (75)
Beginning balance (in shares) at Mar. 31, 2024 266,000 266,415      
Beginning balance at Mar. 31, 2024 $ 7,513 [1] $ 3 0 7,582 (72)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 292     280 12
Stock-based compensation 143   143    
Issuance of common stock (in shares)   1,565      
Issuance of common stock $ (121)   (121)    
Common stock repurchases (in shares) (2,800) (2,847)      
Common stock repurchases and excise tax $ (377)   (22) (355)  
Common stock repurchases and excise tax (375)        
Cash dividends declared ($0.19 per common share) $ (50)     (50)  
Ending balance (in shares) at Jun. 30, 2024 265,000 265,133      
Ending balance at Jun. 30, 2024 $ 7,400 $ 3 $ 0 $ 7,457 $ (60)
[1] Derived from audited Consolidated Financial Statements.